Clinical Trial Update: Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery [Phase 2]

View source ↗

Summary

Pfizer completed a Phase 2 trial evaluating PD 0348292 for preventing venous thromboembolism (deep vein thrombosis and pulmonary embolism) after knee surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Pulmonary Embolism
• Venous Thromboembolism

Drugs mentioned

• PD 0348292

Snippet

Sponsor: Pfizer | Conditions: Venous Thrombosis | Phase 2 | Status: COMPLETED